Aura Biosciences

This study tests a new drug called belzupacap sarotalocan (AU-011) for people whose cancer has spread to the choroid, the layer of blood vessels in the back of the eye. The drug is given as an injection into the eye to see if it is safe and can shrink the tumor. About 24 adults w…

This early-stage trial is testing a new drug called belzupacap sarotalocan (AU-011) for people with a type of bladder cancer that hasn't spread into the muscle layer. The drug is injected directly into the tumor, sometimes with a laser, to see if it's safe and possible to do. Abo…

This study tests a new drug called belzupacap sarotalocan (AU-011) for people with a rare eye cancer (choroidal melanoma) or suspicious spots that could turn into cancer. The drug is activated by a laser to target and destroy cancer cells. About 100 participants will receive eith…

This study tracks how choroidal melanoma and its treatment affect patients' quality of life. About 15 people already in a larger Phase 3 trial will answer questionnaires about their well-being over two years. No new drugs or procedures are tested—only information is collected.